Attenuation of conflict‐induced suppression by clonidine: Indication of anxiolytic activity

Clonidine was tested in a conflict‐induced suppression paradigm (bar pressing for food reward suppressed by electric foot shock) in rats. This drug significantly and dose dependently (25–100 μg/kg) both increased punished responding and decreased unpunished responding. Clonidine at 200 μg/kg had no effect on punished bar pressing, although it markedly inhibited unpunished responding due to sedation. The effect of clonidine on shock‐suppressed lever pressing was prevented by yohimbine 5 mg/kg and partially antagonized by phenoxybenzamine 2.5 mg/kg but was not significantly altered by phenoxybenzamine 1 mg/kg, atropine 5 mg/kg, methysergide 5 mg/kg, or naloxone 10 mg/kg.

[1]  W. Essman,et al.  Current Developments in Psychopharmacology , 2012, Current Developments in Psychopharmacology.

[2]  Louis S. Harris,et al.  Problems of drug dependence, 1979. Proceedings of the 41st Annual Scientific Meeting, The Committee on Problems of Drug Dependence, Inc. , 1981, NIDA research monograph.

[3]  D. Redmond,et al.  CLONIDINE BLOCKS ACUTE OPIATE-WITHDRAWAL SYMPTOMS , 1978, The Lancet.

[4]  M. Billingsley,et al.  The effects of naloxone and picrotoxin on the sedative and anticonflict effects of benzodiazepines. , 1978, Life sciences.

[5]  D. Atrens,et al.  α-Noradrenergic modulation of hypothalamic self-stimulation: Studies employing clonidine, 1-phenylephrine and α-methyl-p-tyrosine☆☆☆ , 1976 .

[6]  B. Bunney,et al.  Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine , 1975, Brain Research.

[7]  S. Nader.  Letter: Storage and transport of serum for prolactin radioimmunoassay. , 1974, Lancet.

[8]  L. Paalzow.  Analgesia produced by clonidine in mice and rats , 1974, The Journal of pharmacy and pharmacology.

[9]  K. Starke,et al.  Inhibition of adrenergic neurotransmission by clonidine: an action on prejunctional -receptors. , 1973, Neuropharmacology.

[10]  H. Hedeland,et al.  Studies on catecholamines, renin and aldosterone following Catapresan (2-(2,6-dichlor-phenylamine)-2-imidazoline hydrochloride) in hypertensive patients. , 1970, European journal of pharmacology.

[11]  K Fuxe,et al.  Evidence for a central noradrenaline receptor stimulation by clonidine. , 1970, Life sciences.

[12]  K. Taylor,et al.  Behavioural and biochemical effects of 2‐(2,6‐dichlorophenylamino)‐2‐imidazoline hydrochloride (St 155) on the central nervous system , 1969, British journal of pharmacology.

[13]  C. Morpurgo.  Aggressive behavior induced by large doses of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride (ST 155) in mice. , 1968, European journal of pharmacology.

[14]  W. Kobinger,et al.  [Pharmacological effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, a new, antihypertensive substance]. , 1966, Arzneimittel-Forschung.

[15]  Fred E. D'Amour,et al.  A METHOD FOR DETERMINING LOSS OF PAIN SENSATION , 1941 .

[16]  R. Rawson,et al.  Clonidine hydrochloride: a nonopiate treatment for opiate withdrawal. , 1979, NIDA research monograph.

[17]  J. B. Lassen.  Piperoxane reduces the effects of clonidine on aggression in mice and on noradrenaline dependent hypermotility in rats , 1978 .

[18]  J. Buus Lassen.  Piperoxane reduces the effects of clonidine on aggression in mice and on noradrenaline dependent hypermotility in rats. , 1978, European journal of pharmacology.

[19]  D. Atrens,et al.  Alpha-noradrenergic modulation of hypothalamic self-stimulation: studies employing clonidine, 1-phenylephrine and alpha-methyl-p-tyrosine. , 1976, European journal of pharmacology.

[20]  M. Lader.  The peripheral and central role of the catecholamines in the mechanisms of anxiety. , 1974, International pharmacopsychiatry.

[21]  S. Z. Langer.  THE REGULATION OF TRANSMITTER RELEASE ELICITED BY NERVE STIMULATION THROUGH A PRESYNAPTIC FEED-BACK MECHANISM , 1973 .